Does Semaglutide Cause Constipation? What to Expect

Does Semaglutide Cause Constipation? How Common It Is and How Long It Lasts

Constipation is one of the most common digestive side effects of semaglutide (Ozempic, Wegovy), affecting roughly 1 in 4 people on the weight-management dose in clinical trials. What trial data shows next is less expected: this particular side effect doesn't run on the same clock as the nausea and diarrhea people usually hear about first. It shows up early in the dosing schedule and, for a meaningful share of users, settles in rather than fading out.

How Common Is Semaglutide Constipation?

How often constipation shows up depends heavily on which dose you're on. In the Wegovy prescribing information, built on the trials that led to FDA approval for weight management, constipation was reported by 24% of people on the 2.4 mg dose versus 11% on placebo. Any gastrointestinal adverse reaction, a broader category that includes constipation alongside nausea, diarrhea, vomiting, abdominal pain, dyspepsia, and several others, hit 73% versus 47%.¹

Ozempic, the lower-dose version of the same drug approved for type 2 diabetes, reports lower numbers: 5.0% of people on 0.5 mg and 3.1% on 1 mg had constipation, compared with 1.5% on placebo.² Those Ozempic numbers alone don't show a clean dose-response relationship (the 1 mg rate is actually lower than 0.5 mg), and the Wegovy and Ozempic trials had different populations and designs, so this isn't a controlled comparison. What's consistent across both drugs' data is that constipation is a recognized, labeled side effect at each maintenance dose reported in these labels, not that risk necessarily climbs in a straight line with dose.

When Does It Start, and How Long Does It Last?

Semaglutide is introduced gradually. The label's standard schedule raises the dose roughly every four weeks across five steps, reaching the 2.4 mg target dose around four months into treatment on the standard protocol (some people's escalation is slower if a step needs to be repeated for tolerability).¹ Constipation can appear at any point along that ramp-up, and it doesn't necessarily wait for the highest dose.

A pooled, post-hoc, exploratory analysis of three major Wegovy trials (2,117 people on semaglutide, 1,262 on placebo, funded by Novo Nordisk with several authors employed by or consulting for the company) gives the clearest picture of the timeline.³ Nausea, diarrhea, and vomiting peaked in frequency around week 20 and declined afterward. Constipation behaved differently: its frequency across the trial population plateaued earlier, around week 10, and stayed more common in the semaglutide group than the placebo group through the rest of the 68-week trial rather than declining.³ This reflects a population-level pattern, not a promise that any one person's symptoms fade by a certain week, and there's no published information on whether individual episodes get milder over time, only on how often they're reported across the group.

Individual episodes also last longer than other GLP-1 digestive complaints. In that same analysis, the median constipation episode lasted 47 days in the semaglutide group versus 35 days on placebo, compared with just 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting.³ If constipation is the GLP-1 side effect you're dealing with, it's reasonable to expect it to stick around longer than the queasiness people usually talk about first.

What Makes Semaglutide Constipation More Likely?

Semaglutide slows gastric emptying as part of how it works, and that effect is well documented in the drug's own label.¹ A clinical review of delayed gastric emptying with GLP-1 drugs found the effect partially fades with continued use, with measurable improvement documented through at least 16 weeks of treatment, though what happens beyond that point isn't established either way.⁴ The same review notes that how full, gassy, or backed up you feel doesn't reliably track with how delayed your gastric emptying actually is, so persistent symptoms alone aren't proof the underlying slowdown hasn't improved.⁴

A few everyday factors compound the effect:

• Eating and drinking less. Appetite suppression is the point of the drug, but lower food and fluid volume overall means less to move things along.
• Lower fiber intake. If a smaller appetite means fewer fruits, vegetables, and whole grains, stool can lose bulk and water content at the same time your gut is already moving more slowly, which is exactly the gap a fiber supplement is built to close when food alone won't get you there (more on that below).
• Being less active. Movement helps stimulate bowel motility; if nausea or fatigue during dose increases has you moving less, that can add to the slowdown.
• The dose-escalation stage you're on. Constipation risk doesn't climb neatly with each dose step, but the labeled rates above show it's already common well before the top dose, so a step-up in your schedule is a reasonable time to get ahead of it rather than wait for it.

When to Call Your Doctor

Occasional constipation on semaglutide is common and usually manageable at home. A few patterns need urgent evaluation instead:

• No bowel movements or passing gas, severe cramping, vomiting, or a visibly swollen abdomen: these can signal a bowel obstruction and need urgent evaluation, not another dose of fiber.⁸ Semaglutide's label separately lists ileus, intestinal obstruction, and severe constipation including fecal impaction among reported postmarketing gastrointestinal events.^1,2
• Severe or worsening abdominal pain, pain that spreads to your back, persistent nausea or vomiting, fever, chills, or yellowing of the skin or eyes: seek care right away for any of these; they can point to pancreatitis.⁵
• Upper-abdominal pain lasting several hours, fever, chills, jaundice, dark urine, or pale stools: see a doctor right away for any of these; they can signal a gallbladder problem.⁶
• Confusion or dizziness that isn't otherwise explained, especially if you're eating and drinking much less than usual: these can point to significant dehydration.⁷

Never stop or adjust your semaglutide dose on your own to manage constipation. That call belongs to the prescriber who's tracking your full picture, including whether the medication itself needs adjusting.

Managing Semaglutide Constipation Day to Day

For most people, semaglutide constipation responds to the same basics that help any slow gut: steady water intake, gradual fiber increases rather than a sudden jump, and regular movement. On semaglutide specifically, your appetite is working against you on the food and fluid front, which is why a lot of people on this medication end up looking for something more targeted to fill that gap.

WonderBiotics Daily Fiber Mix is designed to close exactly that gap. The blend leads with Fibersol® soluble corn fiber, partially hydrolyzed guar gum, and psyllium husk, alongside kale fiber, polydextrose, a smaller amount of FOS, and white kidney bean powder, five fiber sources chosen for a reason: in vitro fermentation testing of the same broad category of resistant, low-viscosity fibers found that slower-fermenting types like these produced meaningfully less gas than fast fermenters like inulin.⁹ That's the whole design logic here, bulk and moisture for a slower gut, without the gas spike of a fast-fermenting formula. If you're sensitive to fiber right now, start with one 6 g sachet rather than the full three and build up from there.

WonderBiotics Probiotics for Gut Health pairs 12 studied strains at 60 billion CFU, anchored by Bifidobacterium animalis subsp. lactis HN019, one of the only probiotic strains with a dedicated human research program built around bowel habits specifically, rather than a strain borrowed from an unrelated category. Across the human trials on HN019, a consistent secondary signal shows up on abdominal comfort and bloating, even in trials where the primary bowel-frequency endpoint didn't reach significance.^10,11,12,13 We include HN019 alongside a multi-enzyme blend and FOS for daily digestive support, the kind of everyday comfort this strain's evidence actually backs, not a standalone treatment for an active bout of constipation.

Neither product has been tested as a finished formula specifically in people taking semaglutide, and we're upfront about that. What we built both around is the ingredients and strains with the most direct human data we could find for regularity and gut comfort, meant to work alongside water, movement, and your prescriber's guidance, as part of the same daily routine, not a replacement for any of it.

References

1. Wegovy (semaglutide) injection prescribing information. DailyMed, setid ee06186f-2aa3-4990-a760-757579d8f77b, Novo Nordisk. DailyMed
2. Ozempic (semaglutide) injection prescribing information. DailyMed, setid adec4fd2-6858-4c99-91d4-531f5f2a2d79, Novo Nordisk Pharmaceutical Industries, LP. DailyMed
3. Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. doi:10.1111/dom.14551. PMID 34514682. doi.org
4. Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab. 2025;110(1):1-15. doi:10.1210/clinem/dgae719. doi.org
5. Pancreatitis - Symptoms & Causes. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). niddk.nih.gov/health-information/digestive-diseases/pancreatitis/symptoms-causes. NIDDK
6. Gallstones - Symptoms & Causes. NIDDK. niddk.nih.gov/health-information/digestive-diseases/gallstones/symptoms-causes. NIDDK
7. Dehydration - Symptoms & causes. Mayo Clinic. mayoclinic.org/diseases-conditions/dehydration/symptoms-causes/syc-20354086. Mayo Clinic
8. Intestinal obstruction - Symptoms & causes. Mayo Clinic. mayoclinic.org/diseases-conditions/intestinal-obstruction/symptoms-causes/syc-20351460. Mayo Clinic
9. Noack J, Timm D, Hospattankar A, Slavin J. Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an In Vitro Digestion Pretreatment and In Vitro Batch Fermentation System Model. Nutrients. 2013;5(5):1500-1510. PMC3708332. PMC
10. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486. PubMed
11. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. doi:10.1080/19490976.2017.1412908. PMID 29227175. doi.org
12. Cheng J, Gao C, Ala-Jaakkola R, et al. Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(10):e2436888. doi:10.1001/jamanetworkopen.2024.36888. PMID 39356506. doi.org
13. Ala-Jaakkola R, et al. Bifidobacterium animalis subsp. lactis HN019 for functional constipation: a multicenter, randomized, triple-blind, placebo-controlled trial. Mol Nutr Food Res. 2025. doi:10.1002/mnfr.70081. PMID 40320938. doi.org